{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:12:58Z","timestamp":1793059978761,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["TTU-2016-23462"],"award-info":[{"award-number":["TTU-2016-23462"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12020-018-1744-8","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T12:16:49Z","timestamp":1536668209000},"page":"692-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-up"],"prefix":"10.1007","volume":"62","author":[{"given":"Emir","family":"Celik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande Mefkure","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burc Cagri","family":"Poyraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Saglam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"key":"1744_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12020-015-0727-2","volume":"51","author":"S Noronha","year":"2016","unstructured":"S. Noronha, V. Stokes, N. Karavitaki, A. Grossman, Treating prolactinomas with dopamine agonists: always worth the gamble? Endocrine 51, 205\u2013210 (2016). \n                    https:\/\/doi.org\/10.1007\/s12020-015-0727-2","journal-title":"Endocrine"},{"key":"1744_CR2","doi-asserted-by":"publisher","first-page":"R88","DOI":"10.1530\/ec-18-0030","volume":"7","author":"AP Athanasoulia-Kaspar","year":"2018","unstructured":"A.P. Athanasoulia-Kaspar, K.H. Popp, G.K. Stalla, Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist. Endocr. Connect. 7, R88\u2013r94 (2018). \n                    https:\/\/doi.org\/10.1530\/ec-18-0030","journal-title":"Endocr. Connect."},{"key":"1744_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","volume":"133","author":"D Weintraub","year":"2017","unstructured":"D. Weintraub, D.O. Claassen, Impulse control and related disorders in Parkinson\u2019s disease. Int. Rev. Neurobiol. 133, 679\u2013717 (2017). \n                    https:\/\/doi.org\/10.1016\/bs.irn.2017.04.006","journal-title":"Int. Rev. Neurobiol."},{"key":"1744_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/bs4040352","volume":"4","author":"A Kocka","year":"2014","unstructured":"A. Kocka, J. Gagnon, Definition of impulsivity and related terms following traumatic brain injury: A review of the different concepts and measures used to assess impulsivity, disinhibition and other related concepts. Behav. Sci. (Basel) 4, 352\u2013370 (2014). \n                    https:\/\/doi.org\/10.3390\/bs4040352","journal-title":"Behav. Sci. (Basel)"},{"key":"1744_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11065-015-9306-9","volume":"25","author":"PJ Rossi","year":"2015","unstructured":"P.J. Rossi, A. Gunduz, M.S. Okun, The subthalamic nucleus, limbic function, and impulse control. Neuropsychol. Rev. 25, 398\u2013410 (2015). \n                    https:\/\/doi.org\/10.1007\/s11065-015-9306-9","journal-title":"Neuropsychol. Rev."},{"key":"1744_CR6","first-page":"71","volume":"43","author":"PN Dannon","year":"2006","unstructured":"P.N. Dannon, R. Mester, Editorial: Impulse control disorders: does the DSM-IV classification really explain everything about this type of disorder? Isr. J. Psychiatry Relat. Sci. 43, 71\u201373 (2006)","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"1744_CR7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/cen.12375","volume":"80","author":"I Bancos","year":"2014","unstructured":"I. Bancos, M.R. Nannenga, J.M. Bostwick, M.H. Silber, D. Erickson, T.B. Nippoldt, Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study. Clin. Endocrinol. (Oxf.). 80, 863\u2013868 (2014). \n                    https:\/\/doi.org\/10.1111\/cen.12375","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"1744_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s12020-017-1247-z","volume":"56","author":"I Bancos","year":"2017","unstructured":"I. Bancos, T.B. Nippoldt, D. Erickson, Hypersexuality in men with prolactinomas treated with dopamine agonists. Endocrine 56, 456\u2013457 (2017). \n                    https:\/\/doi.org\/10.1007\/s12020-017-1247-z","journal-title":"Endocrine"},{"key":"1744_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11102-013-0480-6","volume":"17","author":"M Barake","year":"2014","unstructured":"M. Barake, A.E. Evins, L. Stoeckel, G.N. Pachas, L.B. Nachtigall, K.K. Miller, B.M. Biller, N.A. Tritos, A. Klibanski, Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study. Pituitary 17, 150\u2013156 (2014). \n                    https:\/\/doi.org\/10.1007\/s11102-013-0480-6","journal-title":"Pituitary"},{"key":"1744_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12020-016-1088-1","volume":"55","author":"SM Sousa De","year":"2017","unstructured":"S.M. De Sousa, I.M. Chapman, H. Falhammar, D.J. Torpy, Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endocrine 55, 618\u2013624 (2017). \n                    https:\/\/doi.org\/10.1007\/s12020-016-1088-1","journal-title":"Endocrine"},{"key":"1744_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.psychres.2018.05.006","volume":"265","author":"SR Chamberlain","year":"2018","unstructured":"S.R. Chamberlain, J.E. Grant, Minnesota impulse disorders interview (MIDI): Validation of a structured diagnostic clinical interview for impulse control disorders in an enriched community sample. Psychiatry Res. 265, 279\u2013283 (2018). \n                    https:\/\/doi.org\/10.1016\/j.psychres.2018.05.006","journal-title":"Psychiatry Res."},{"key":"1744_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.paid.2009.04.008","volume":"47","author":"MS Stanford","year":"2009","unstructured":"M.S. Stanford, C.W. Mathias, D.M. Dougherty, S.L. Lake, N.E. Anderson, J.H. Patton, Fifty years of the Barratt Impulsiveness Scale: An update and review. Pers. Individ. Dif. 47, 385\u2013395 (2009). \n                    https:\/\/doi.org\/10.1016\/j.paid.2009.04.008","journal-title":"Pers. Individ. Dif."},{"key":"1744_CR13","first-page":"251","volume":"18","author":"H G\u00fcle\u00e7","year":"2008","unstructured":"H. G\u00fcle\u00e7, L. Tamam, M. Yazici, M. Turhan, G. Karaku\u015f, M. Zengin, M. Stanford, Psychometric properties of the Turkish Version of the Barratt Impulsiveness Scale-11. Klin. Psikofarmakol. Bul. 18, 251\u2013258 (2008)","journal-title":"Klin. Psikofarmakol. Bul."},{"key":"1744_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","volume":"8","author":"AT Beck","year":"1988","unstructured":"A.T. Beck, R.A. Steer, M.G. Carbin, Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin. Psychol. Rev. 8, 77\u2013100 (1988). \n                    https:\/\/doi.org\/10.1016\/0272-7358(88)90050-5","journal-title":"Clin. Psychol. Rev."},{"issue":"6","key":"1744_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"A. T. BECK","year":"1961","unstructured":"Beck, A. T., Ward, C. H., Mendelson, M., Mock, J. E., Erbaugh, J. T. An inventory for measuring depression. Arch. Gen. Psychiatry 4, (1961) \n                    https:\/\/doi.org\/10.1001\/archpsyc.1961.01710120031004","journal-title":"Archives of General Psychiatry"},{"key":"1744_CR16","first-page":"163","volume":"12","author":"M Ulusoy","year":"1998","unstructured":"M. Ulusoy, N.H. Sahin, H. Erkmen, Turkish version of the Beck Anxiety Inventory; Psychometric properties. J. Cogn. Psychother. 12, 163\u2013172 (1998)","journal-title":"J. Cogn. Psychother."},{"key":"1744_CR17","first-page":"118","volume":"6","author":"N Hisli","year":"1988","unstructured":"N. Hisli, A study on the validity of the beck depression inventory. J. Psychol. 6, 118\u2013122 (1988)","journal-title":"J. Psychol."},{"key":"1744_CR18","unstructured":"Derogatis, L. R., SCL-90-R, Administration, Scoring and Procedures Manual-ii for the R(evised) Version and Other Instruments of the Psychopathology Rating Scale Series. (Clinical Psychometric Research, Townson, 1992)"},{"key":"1744_CR19","first-page":"45","volume":"1","author":"M K\u0131l\u0131\u00e7","year":"1991","unstructured":"M. K\u0131l\u0131\u00e7, Belirti Tarama Listesi (SCL-90-R)\u2018nin Ge\u00e7erlilik ve G\u00fcvenirli\u011fi. T\u00fcrk Psikol. Dan\u0131\u015fma ve Rehb. Derg. 1, 45\u201352 (1991)","journal-title":"T\u00fcrk Psikol. Dan\u0131\u015fma ve Rehb. Derg."},{"key":"1744_CR20","first-page":"248","volume":"49","author":"RB Krueger","year":"2012","unstructured":"R.B. Krueger, M.S. Kaplan, Paraphilic diagnoses in DSM-5. Isr. J. Psychiatry Relat. Sci. 49, 248\u2013254 (2012)","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"1744_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"D. Weintraub, J. Koester, M.N. Potenza, A.D. Siderowf, M. Stacy, V. Voon, J. Whetteckey, G.R. Wunderlich, A.E. Lang, Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch. Neurol. 67, 589\u2013595 (2010). \n                    https:\/\/doi.org\/10.1001\/archneurol.2010.65","journal-title":"Arch. Neurol."},{"key":"1744_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mds.25291","volume":"28","author":"J Bastiaens","year":"2013","unstructured":"J. Bastiaens, B.J. Dorfman, P.J. Christos, M.J. Nirenberg, Prospective cohort study of impulse control disorders in Parkinson\u2019s disease. Mov. Disord. 28, 327\u2013333 (2013). \n                    https:\/\/doi.org\/10.1002\/mds.25291","journal-title":"Mov. Disord."},{"key":"1744_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/WNF.0b013e3182281b2f","volume":"34","author":"J Martinkova","year":"2011","unstructured":"J. Martinkova, L. Trejbalova, M. Sasikova, J. Benetin, P. Valkovic, Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas. Clin. Neuropharmacol. 34, 179\u2013181 (2011). \n                    https:\/\/doi.org\/10.1097\/WNF.0b013e3182281b2f","journal-title":"Clin. Neuropharmacol."},{"key":"1744_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1360-0443.2010.03218.x","volume":"106","author":"P Ambermoon","year":"2011","unstructured":"P. Ambermoon, A. Carter, W.D. Hall, N.N. Dissanayaka, J.D. O\u2019Sullivan, Impulse control disorders in patients with Parkinson\u2019s disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction 106, 283\u2013293 (2011). \n                    https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03218.x","journal-title":"Addiction"},{"key":"1744_CR25","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.5665\/sleep.3044","volume":"36","author":"S Bayard","year":"2013","unstructured":"S. Bayard, M.C. Langenier, Y. Dauvilliers, Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome. Sleep 36, 1501\u20131507 (2013). \n                    https:\/\/doi.org\/10.5665\/sleep.3044","journal-title":"Sleep"},{"key":"1744_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/adb.12381","volume":"21","author":"L Fattore","year":"2016","unstructured":"L. Fattore, M. Melis, Sex differences in impulsive and compulsive behaviors: a focus on drug addiction. Addict. Biol. 21, 1043\u20131051 (2016). \n                    https:\/\/doi.org\/10.1111\/adb.12381","journal-title":"Addict. Biol."},{"key":"1744_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1517\/14740338.2016.1151493","volume":"15","author":"RS Auriemma","year":"2016","unstructured":"R.S. Auriemma, L.F. Grasso, R. Pivonello, A. Colao, The safety of treatments for prolactinomas. Expert. Opin. Drug. Saf. 15, 503\u2013512 (2016). \n                    https:\/\/doi.org\/10.1517\/14740338.2016.1151493","journal-title":"Expert. Opin. Drug. Saf."},{"key":"1744_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000335996","volume":"96","author":"AP Athanasoulia","year":"2012","unstructured":"A.P. Athanasoulia, M. Ising, H. Pfister, C.S. Mantzoros, G.K. Stalla, C. Sievers, Distinct dopaminergic personality patterns in patients with prolactinomas: A comparison with nonfunctioning pituitary adenoma patients and age- and gender-matched controls. Neuroendocrinology 96, 204\u2013211 (2012)","journal-title":"Neuroendocrinology"},{"key":"1744_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1530\/eje-12-0198","volume":"167","author":"AP Athanasoulia","year":"2012","unstructured":"A.P. Athanasoulia, C. Sievers, M. Ising, A.C. Brockhaus, A. Yassouridis, G.K. Stalla, M. Uhr, Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas. Eur. J. Endocrinol. 167, 327\u2013335 (2012). \n                    https:\/\/doi.org\/10.1530\/eje-12-0198","journal-title":"Eur. J. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1744-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1744-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1744-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T20:29:00Z","timestamp":1569961740000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1744-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1744"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1744-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]},"assertion":[{"value":"27 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}